Lek voted most reputable employer for the fifth year in a row
- In a survey conducted by the job portal Mojedelo.com to measure the reputation of employers, Lek, a Sandoz company, was voted the most reputable employer in Slovenia by job seekers.
- This is the fifth consecutive year Lek has won this prestigious award, and the sixth overall.
- The title of Most Reputable Employer acknowledges that Lek's long-standing efforts to develop a quality work environment built on the values of diversity, inclusion and fairness have created a lasting reputation in the mind of the public.
Lek, a Sandoz company, has been awarded the title of Most Reputable Employer 2023, presented by the job portal Mojedelo.com since 2007.
In addition to the overall title of Most Reputable Employer, Lek also won the same award in four of the individual categories.
Robert Ljoljo, President of the Lek Board of Management and Sandoz Country President Slovenia, emphasized that Lek's high reputation among candidates on the labor market is the result of a focused development of a supportive and quality work environment based on diversity, fairness and inclusiveness, and added:
| "The remarkable story of Lek, Slovenia's oldest pharmaceutical company and pioneer in biosimilar development and production, is based on values of innovation, courage, perseverance and commitment. Values that unite us today in our purpose to pioneer access for patients. | Robert Ljoljo - President of the Lek Board of Management |
Our associates play a key role in this, working together to build our culture of empowerment and agility, which is the key to staying ahead in the challenging pharmaceutical market. We are creating an environment where they feel comfortable and valued for their skills and contributions. An environment that encourages open communication, continuous learning, collaboration and creativity so they can reach their full potential. I am delighted that our efforts and the values that we live by at Lek are being recognized from the outside. And I am particularly proud that we have maintained our reputation as a responsible employer in a challenging year.“
A strong, supportive and inspiring culture unites more than 3,700 Lek associates, who find many opportunities for professional and career development within a global pharmaceutical company. The wide range of programs for associates, the focus on talent development, and the daily efforts to create a supportive working environment are complemented by approaches to create advanced, hybrid forms of working with active solutions supported by digitalization. They support their associates in achieving a good work-life balance through their Energized for Life program, and they actively involve them in continuous improvement through their Think Sandoz app, which allows any associate to suggest and evaluate improvements. Another such example is the award-winning HR initiative, the Youth Advisory Board, which enables their associates to contribute to the development of Lek's professional and business environment.
One of Lek's key objectives is to become and remain the first choice for the most promising and talented people, with a strong focus on identifying, developing and motivating young talent that will play an important role in the company's continued growth and innovation. They are reaching out to students and professionals from various fields, giving them the opportunity to work with foreign experts in the international environment of Sandoz's global network, acquire new knowledge and skills, unleash their talents and creativity, and build their careers.
They open up new horizons and career opportunities for young people in the pharmaceutical industry by offering scholarships, internships and opportunities to complete academic theses, bachelor's, master's and doctoral degrees. They also organize special projects and events for young talent, and showcase the work of Lek and the pharmaceutical industry at events organized by others.
One such project is ScienceBEAT, a Golden Practice 2023 award winning scientific and professional event that gives young talent access to a global network of professional excellence in science and entrepreneurship. The competitiveness and reputation of Lek's efforts in the field of human resources are also confirmed by numerous other national and international awards, including the prestigious international Top Employer 2024 certificate, awarded by the independent Top Employer Institute, and the TOP Investor in Education certificate.
About Lek
Lek, a Sandoz company, is the first and oldest pharmaceutical company in Slovenia, developing, manufacturing and marketing effective, safe and high-quality generics and biosimilars for patients around the world. Our work is guided by strong ethical standards, innovative thinking and the breakthrough achievements of our world-class professionals. With more than 3,700 associates, we have been actively shaping the Slovenian, European and global research and development landscape for decades. We are building a culture of open dialog, and we proudly and responsibly hold the title of most reputable employer in Slovenia.
About Sandoz
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 800 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1500 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the first biosimilar in 2006. In 2023, Sandoz recorded sales of USD 9.6 billion.
Disclaimer
This Media Release contains forward-looking statements which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside of the control of Sandoz. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sandoz undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
